A phase III, randomized, open-label study evaluating efficacy and safety of Giredestrant compared with Fulvestrant, both combined with a CDK4/6 inhibitor, in patients with estrogen receptor-positive, HER2-negative advanced breast cancer with resistance to prior adjuvant endocrine therapy - pionERA
A Phase III, Multicenter, Randomized, Double-Masked, Sham-Controlled Study To Investigate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of RO7200220 Administered Intravitreally In Patients With Uveitic Macular Edema
A Phase III, Open-Label, Randomized Study Of Atezolizumab With Lenvatinib Or Sorafenib Versus Lenvatinib Or Sorafenib Alone In Hepatocellular Carcinoma Previously Treated With Atezolizumab And Bevacizumab.
100 项与 Roche Products (India) Pvt Ltd. 相关的临床结果
0 项与 Roche Products (India) Pvt Ltd. 相关的专利(医药)
100 项与 Roche Products (India) Pvt Ltd. 相关的药物交易
100 项与 Roche Products (India) Pvt Ltd. 相关的转化医学